Clinical Trials
7 trialsNCT02445391 2026-05-12
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting
NCT02546934 2022-04-22
TNBC
Fudan University
Phase 3 Completed
NCT00003032 2020-04-01
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer
Canadian Cancer Trials Group
Phase 3 Completed
NCT00002836 2018-11-06
Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer
M.D. Anderson Cancer Center
Phase 3 Completed
NCT03006614 2017-01-16
PERS
Sun Yat-sen University
Phase 3 Unknown
NCT01287624 2015-03-23
TNBC
Fudan University
Phase 3 Completed
NCT00002772 2013-01-24
S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer
SWOG Cancer Research Network
Phase 3 Terminated